Glycemia Reduction in Type 2 Diabetes - Microvascular and Cardiovascular Outcomes.
null nullDavid M NathanJohn M LachinIonut BebuHenry B BurchJohn B BuseAndrea L CherringtonStephen P FortmannJennifer B GreenSteven E KahnM Sue KirkmanHeidi Krause-SteinraufMary E LarkinLawrence S PhillipsRodica Pop-BusuiMichael SteffesMargaret TiktinMark TripputiDeborah J WexlerNaji YounesPublished in: The New England journal of medicine (2022)
In participants with type 2 diabetes, the incidences of microvascular complications and death were not materially different among the four treatment groups. The findings indicated possible differences among the groups in the incidence of any cardiovascular disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others; GRADE ClinicalTrials.gov number, NCT01794143.).